All articles
How Long Does It Take for Zepbound to Work? A Week-by-Week Timeline
Reading time:
11 mins
Weight loss

A Slow Start Doesn't Mean Zepbound Isn't Working
If you haven't lost 5% by week 12, you're not alone. In the same analysis, 278 participants, or 18%, were under 5% at week 12 (3). By week 72, 90% of those slower responders had reached at least 5% (3).
On average, the slower group took about 25 weeks to reach 5% (3). And 70% of them got there by week 24, the end of dose increases in that analysis (3). Slower responders were more likely to be male and started with a higher average weight and BMI (3).
A 2026 analysis of SURMOUNT-1 and SURMOUNT-2, which enrolled people with type 2 diabetes, used an earlier cutoff: 5% at week 8 (5). Both early and later responders reached clinically meaningful weight reduction by week 72, though early responders lost more on average (5). The pattern and timing of stomach-related side effects were similar in both groups (5).
So a slow first month isn't a verdict. If you're worried about your pace, ask your provider about when to titrate up instead of changing anything on your own.
Weight Loss Keeps Building for More Than a Year
In SURMOUNT-1, 2,539 adults took tirzepatide or placebo for 72 weeks. Average weight loss at week 72 was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, compared with 3.1% on placebo (SURMOUNT-1, NEJM) (2). In the 10 mg and 15 mg groups, 50% and 57% of people lost 20% or more, versus 3% on placebo (2).
When does it level off? A 2025 analysis measured the time to a weight plateau, defined as less than 5% change over a 12-week stretch and every stretch after it (4). Median time to plateau ranged from about 24 weeks in people with overweight to about 36 weeks in people with class II or III obesity (4). By week 72, roughly 88% to 90% had reached a plateau (4).
Some groups reached a plateau later. That included people on 10 mg or 15 mg, younger people and women (4).
A plateau after months of loss is an expected phase. In obesity treatment, the rate of weight loss slows over time and eventually levels off (4). If you've hit one, here's more on the GLP-1 plateau.
Sleep Apnea Results Were Measured at One Year
If you take Zepbound for obstructive sleep apnea, the trial timeline was longer. In the SURMOUNT-OSA trials, adults with moderate to severe sleep apnea and obesity took their maximum tolerated dose, 10 mg or 15 mg, for 52 weeks (7).
The apnea-hypopnea index, or AHI, counts how many times per hour your breathing stops or turns shallow during sleep. At week 52, AHI fell by 25.3 events per hour in people not using a PAP machine and by 29.3 in people already using one (7). With placebo, it fell by about 5 events per hour (7).
The maintenance dose for sleep apnea is 10 mg or 15 mg (1). Moving up in four-week steps, you'd be on Zepbound for at least 12 weeks before reaching 10 mg (1). That's one more reason sleep apnea results take time.
How to Tell If Zepbound Is Working
The scale is only one signal. A simple routine helps you see real trends instead of daily swings, and it gives your provider useful information at each check-in.
Weigh in weekly, not daily. Pick the same day and time each week, before breakfast, in similar clothing.
Compare month to month. Your weight naturally moves around from day to day. A four-week trend tells you more.
Use 5% as a reference point. That's the threshold SURMOUNT-1 used for a meaningful response (2). Do the math on your own starting weight.
Measure your waist once a month. It gives you a second number to watch besides the scale.
Note appetite and portions. Are you full sooner? Thinking about food less? Write it down.
Log side effects and missed doses. If you miss a dose, the label says to take it within 4 days (96 hours); if more than 4 days have passed, skip it and take the next dose on your usual day (1).
Bring your notes to every check-in, especially around week 12.
Want a licensed provider to review your progress or your options? Check your eligibility through Mochi Health.
Five Things Shape How Fast Zepbound Works for You
How long for Zepbound to work depends on factors you can see in the trial data: your dose, how consistently you take it, how you tolerate it, your starting weight and the habits it's paired with.
Your dose. Higher doses produced more average weight loss at 72 weeks in SURMOUNT-1 (2). They also take longer to reach.
Consistency. The 82% figure at week 12 comes from people who took at least 75% of their doses (3). Those numbers reflect people who stayed on a steady weekly schedule.
How you tolerate it. Stomach-related side effects were the most common in SURMOUNT-1, mostly mild to moderate, and they happened mainly during dose increases (2). If side effects make it hard to keep going, tell your provider. The label allows a lower maintenance dose when one isn't tolerated (1).
Your starting point. People with a higher starting BMI took longer to reach a plateau (4). Slower early responders were also heavier at baseline (3).
Diet and activity. Zepbound is approved for use together with a reduced-calorie diet and more physical activity (1). The medication and your habits work as a pair.
If you've searched "Zepbound how long does it take to work" hoping for one number, this is why there isn't one.
Stopping Too Soon Can Reverse Progress
SURMOUNT-4 tested what happens when people stop. After 36 weeks on their maximum tolerated dose, 670 adults who had lost an average of 20.9% were randomly assigned to keep taking tirzepatide or switch to placebo for 52 more weeks (6).
The difference was large. People switched to placebo gained back an average of 14.0% of their body weight, while people who stayed on tirzepatide lost another 5.5% (6). At week 88, 89.5% of the tirzepatide group had kept at least 80% of their earlier weight loss, compared with 16.6% on placebo (6).
The researchers concluded that stopping tirzepatide led to substantial regain, while continuing treatment maintained and added to the weight loss (6).
So the question of how long it takes Zepbound to work has a second half: how long you stay on it. That's a decision to make with your provider. Don't stop or change your dose without talking to them first.
Thyroid History Is the First Safety Question
Zepbound has a boxed warning for thyroid C-cell tumors. In rats, tirzepatide causes thyroid C-cell tumors. It is unknown whether Zepbound causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans (1). A provider will discuss this with you.
You should not use Zepbound if you or a family member has had MTC, or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2) (1). The same goes if you've had a serious allergic reaction to tirzepatide or any ingredient in it (1).
The most common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, tiredness, allergic reactions, burping, hair loss and acid reflux (1). Because Zepbound slows stomach emptying, tell your care team you're taking it before any surgery or procedure that uses anesthesia or deep sedation (1).
For a fuller list, read about Zepbound side effects.
Brand-Name and Compounded Tirzepatide Are Both Options
Through Mochi Health, affiliated Mochi Medical providers can prescribe FDA-approved tirzepatide (Zepbound) as well as compounded tirzepatide when appropriate. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality.
The timelines and results in this article come from studies of Zepbound. They don't describe compounded tirzepatide, and the two are not interchangeable.
Which option fits you, if either, is your provider's call after reviewing your health history. If you plan to use insurance for Zepbound, Mochi's team can help with prior authorization paperwork.
The Bottom Line
Zepbound starts acting within about a day, but weight loss is measured in weeks and months. The first four weeks are a starter dose (1). In a SURMOUNT-1 analysis, most participants who took most of their doses had lost 5% by week 12, slower starters often caught up, and average loss kept building toward week 72 (2,3).
Give it time, take it consistently, and track trends rather than single weigh-ins. If you'd like to talk with a licensed provider about whether Zepbound or another option fits you, check your eligibility.
FAQs
How Long Does It Take Zepbound to Start Working?
Zepbound reaches its peak level in your blood about 24 hours after a dose, and steady levels after about four weeks of weekly shots (1). Weight loss usually takes longer to show. In a SURMOUNT-1 analysis, 82% of participants who took most of their doses had lost at least 5% by week 12 (3).
Will I Lose Weight on 2.5 mg of Zepbound?
The 2.5 mg dose isn't meant to be your long-term dose. The label says it's for starting treatment and is not approved as a maintenance dose (1). After four weeks, the dose increases to 5 mg (1).
What Should I Expect in My First Week on Zepbound?
The drug is active within about a day (1). Stomach-related side effects such as nausea are the most common (1). In SURMOUNT-1, they happened mostly during dose increases (2). Don't expect big changes on the scale yet.
Should I Take Zepbound in the Morning or at Night?
Either works. The label says to take Zepbound once a week at any time of day, with or without meals (1). Picking the same day each week makes it easier to stay consistent.
Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, for subcutaneous use. Prescribing information. DailyMed, U.S. National Library of Medicine; revised August 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038. PMID: 35658024. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Ard J, Lee CJ, Gudzune K, et al. Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1. Diabetes Obes Metab. 2025;27(9):5064-5071. doi:10.1111/dom.16554. PMID: 40677091; PMCID: PMC12326891.
Horn DB, Kahan S, Batterham RL, et al. Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials. Clin Obes. 2025;15(3):e12734. doi:10.1111/cob.12734. PMID: 39800653; PMCID: PMC12096058.
Kokkinos A, Thethi T, Lee CJ, et al. Tirzepatide efficacy and tolerability according to early weight response: A post hoc analysis of the SURMOUNT-1 and SURMOUNT-2 trials. Diabetes Obes Metab. 2026;28(9):8367-8377. doi:10.1111/dom.71009. PMID: 42348366; PMCID: PMC13448863.
Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38-48. doi:10.1001/jama.2023.24945. PMID: 38078870; PMCID: PMC10714284.
Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205. doi:10.1056/NEJMoa2404881. PMID: 38912654; PMCID: PMC11598664.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Zepbound (tirzepatide) and compounded tirzepatide require a written prescription from a licensed provider. Speak with a provider to determine if Zepbound or compounded tirzepatide is appropriate for you. Zepbound is FDA-approved, in combination with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight and at least one weight-related condition, and to treat moderate to severe obstructive sleep apnea in adults with obesity. Zepbound has a boxed warning for the risk of thyroid C-cell tumors that a provider will discuss with you. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.
Share this post
Weight loss
More articles





